An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis

Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1) inhibitors are an innovative and futuristic orally active group of antituberculosis agents. A few DprE1 inhibitors are in the clinical trial for tuberculosis (TB), including macozinone. This review highlights the discovery, developmental status,...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohd. Imran (Author), Shah Alam Khan (Author), Syed Mohammed Basheeruddin Asdaq (Author), Mazen Almehmadi (Author), Osama Abdulaziz (Author), Mehnaz Kamal (Author), Mohammed Kanan Alshammari (Author), Lojain Ibrahim Alsubaihi (Author), Khansa Hamza Hussain (Author), Abrar Saleh Alharbi (Author), A. Khuzaim Alzahrani (Author)
Format: Book
Published: Elsevier, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available